# Cedars-Sinai investigators have identified a drug-like compound that prevents two proteins from working together to promote the growth of colorectal and liver.

*biotech · news · 2026-04-06 · Medical Xpress*

## Key points

- Cedars-Sinai researchers identified a compound, C3, that disrupts GIT1 and MAT2B protein interaction.
- C3 slows cancer cell growth and induces cell death in colorectal and liver cancer models.
- GIT1 is overactive in many cancers, suggesting C3 could have broad therapeutic applications.
- The compound is in preclinical stages and will be refined for greater effectiveness.

[Read the full story on Medical Xpress](https://medicalxpress.com/news/2026-04-scientists-key-protein-duo-colon.html)

---

Canonical: https://newsio.io/n/3e112d82-97e9-4b4b-b7d2-52233ac51dd5/cedars-sinai-investigators-have-identified-a-drug-like-compound-that-prevents-tw
Summarized by Newsio from Medical Xpress. https://newsio.io/how-it-works